Nos actualités et évènements

Monday, March 18th 2019 at 3:00am UTC HONG KONG–(BUSINESS WIRE)– Hong Kong, The HKTDC Hong Kong International Medical and Healthcare Fair (Medical Fair) will take place at the Hong Kong Convention and Exhibition Centre (HKCEC) from 14 to 16 May. Organised by the Hong Kong Trade Development Council (HKTDC) and co-organised by the Hong Kong […]

Sunday, March 17th 2019 at 3:45pm UTC AUGUSTUS is the largest trial in this high-risk patient population requiring both anticoagulant and antiplatelet therapies PRINCETON, N.J. & NEW YORK–(BUSINESS WIRE)– The Bristol-Myers Squibb–Pfizer Alliance today announced results from the Phase 4 AUGUSTUS trial evaluating Eliquis® (apixaban) versus vitamin K antagonists (VKAs) in patients with non-valvular atrial […]

Saturday, March 16th 2019 at 4:45pm UTC Exploratory analyses of ARIEL3 Rubraca data in recurrent ovarian cancer presented in oral plenary and poster sessions Maintenance treatment with Rubraca improved median progression-free survival (PFS) and reduced the risk of progression vs placebo regardless of age subgroup Maintenance treatment with Rubraca significantly improved PFS and reduced the […]

Saturday, March 16th 2019 at 2:00pm UTC Stanford researchers presented preliminary findings from a virtual study that enrolled more than 400,000 participants. PALO ALTO, Calif.–(BUSINESS WIRE)– Researchers from the Stanford University School of Medicine today presented preliminary results of the Apple Heart Study, an unprecedented virtual study with over 400,000 enrolled participants. The researchers reported […]

Friday, March 15th 2019 at 8:05pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended […]

Friday, March 15th 2019 at 8:17pm UTC TAMPA, Fla.–(BUSINESS WIRE)– Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, today announces the enrollment of the 60th patient in its Phase 2 double blind, placebo controlled clinical trial of AG013 (NCT03234465). AG013 is […]

Friday, March 15th 2019 at 8:33pm UTC HAYWARD, Calif.–(BUSINESS WIRE)– Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse Biosciences” or the “Company”), a novel medical therapy company bringing to market its proprietary CellFX™ System, announced today that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 61,000 shares of […]

Friday, March 15th 2019 at 6:57pm UTC Considering the implications for diagnosis and treatment LOS ANGELES–(BUSINESS WIRE)– Research performed over the last several decades has led to an increased understanding of the genetics of cancer. The clinical application of this knowledge for pediatric cancer has lagged behind studies performed for adults. In a perspectives article […]

Friday, March 15th 2019 at 5:02pm UTC GREENVILLE, SC.–(BUSINESS WIRE)– KIYATEC, Inc. today announced that the company has opened Inova Health System (Inova) and Roswell Park Comprehensive Care Center as sites for its U.S. clinical study, 3D-PREDICT, to validate the company’s test as a patient-specific predictor of response to cancer therapies in ovarian, glioblastoma (GBM) […]

Friday, March 15th 2019 at 5:58pm UTC TORONTO–(BUSINESS WIRE)– Enigma Biomedical Group (EBG) today announced an exclusive license agreement with Merck, known as MSD outside the US and Canada, for the global development and commercialization of MK-6884, an early stage investigational imaging agent developed by Merck for use in Positron Emission Tomography (PET) scans to […]